These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 24583930

  • 1. Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.
    Kwilasz AJ, Abdullah RA, Poklis JL, Lichtman AH, Negus SS.
    Behav Pharmacol; 2014 Apr; 25(2):119-29. PubMed ID: 24583930
    [Abstract] [Full Text] [Related]

  • 2. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
    Scherma M, Medalie J, Fratta W, Vadivel SK, Makriyannis A, Piomelli D, Mikics E, Haller J, Yasar S, Tanda G, Goldberg SR.
    Neuropharmacology; 2008 Jan; 54(1):129-40. PubMed ID: 17904589
    [Abstract] [Full Text] [Related]

  • 3. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J, Lai Y, Takacs SM, Bradshaw HB, Hohmann AG.
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
    Jiang HX, Ke BW, Liu J, Ma G, Hai KR, Gong DY, Yang Z, Zhou C.
    Anesth Analg; 2019 Aug; 129(2):587-597. PubMed ID: 29863609
    [Abstract] [Full Text] [Related]

  • 5. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
    Cippitelli A, Cannella N, Braconi S, Duranti A, Tontini A, Bilbao A, Defonseca FR, Piomelli D, Ciccocioppo R.
    Psychopharmacology (Berl); 2008 Jul; 198(4):449-60. PubMed ID: 18446329
    [Abstract] [Full Text] [Related]

  • 6. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system.
    Okine BN, Norris LM, Woodhams S, Burston J, Patel A, Alexander SP, Barrett DA, Kendall DA, Bennett AJ, Chapman V.
    Br J Pharmacol; 2012 Oct; 167(3):627-40. PubMed ID: 22595021
    [Abstract] [Full Text] [Related]

  • 7. Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain.
    Hama AT, Germano P, Varghese MS, Cravatt BF, Milne GT, Pearson JP, Sagen J.
    PLoS One; 2014 Oct; 9(5):e96396. PubMed ID: 24788435
    [Abstract] [Full Text] [Related]

  • 8. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates.
    Justinova Z, Mangieri RA, Bortolato M, Chefer SI, Mukhin AG, Clapper JR, King AR, Redhi GH, Yasar S, Piomelli D, Goldberg SR.
    Biol Psychiatry; 2008 Dec 01; 64(11):930-7. PubMed ID: 18814866
    [Abstract] [Full Text] [Related]

  • 9. Effect of Fatty Acid Amide Hydrolase Inhibitor URB597 on Orofacial Pain Perception in Rats.
    Zubrzycki M, Zubrzycka M, Wysiadecki G, Szemraj J, Jerczynska H, Stasiolek M.
    Int J Mol Sci; 2022 Apr 23; 23(9):. PubMed ID: 35563056
    [Abstract] [Full Text] [Related]

  • 10. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
    Starowicz K, Makuch W, Korostynski M, Malek N, Slezak M, Zychowska M, Petrosino S, De Petrocellis L, Cristino L, Przewlocka B, Di Marzo V.
    PLoS One; 2013 Apr 23; 8(4):e60040. PubMed ID: 23573230
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats.
    Scherma M, Panlilio LV, Fadda P, Fattore L, Gamaleddin I, Le Foll B, Justinová Z, Mikics E, Haller J, Medalie J, Stroik J, Barnes C, Yasar S, Tanda G, Piomelli D, Fratta W, Goldberg SR.
    J Pharmacol Exp Ther; 2008 Nov 23; 327(2):482-90. PubMed ID: 18725543
    [Abstract] [Full Text] [Related]

  • 12. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
    Forget B, Guranda M, Gamaleddin I, Goldberg SR, Le Foll B.
    Psychopharmacology (Berl); 2016 May 23; 233(10):1823-8. PubMed ID: 26864774
    [Abstract] [Full Text] [Related]

  • 13. Effects of alterations in cannabinoid signaling, alone and in combination with morphine, on pain-elicited and pain-suppressed behavior in mice.
    Miller LL, Picker MJ, Umberger MD, Schmidt KT, Dykstra LA.
    J Pharmacol Exp Ther; 2012 Jul 23; 342(1):177-87. PubMed ID: 22514333
    [Abstract] [Full Text] [Related]

  • 14. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.
    Vlachou S, Nomikos GG, Panagis G.
    Psychopharmacology (Berl); 2006 Oct 23; 188(3):293-305. PubMed ID: 16953388
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice.
    Hoyer FF, Khoury M, Slomka H, Kebschull M, Lerner R, Lutz B, Schott H, Lütjohann D, Wojtalla A, Becker A, Zimmer A, Nickenig G.
    J Mol Cell Cardiol; 2014 Jan 23; 66():126-32. PubMed ID: 24286707
    [Abstract] [Full Text] [Related]

  • 16. Effects of nicotinic acetylcholine receptor agonists in assays of acute pain-stimulated and pain-depressed behaviors in rats.
    Freitas KC, Carroll FI, Negus SS.
    J Pharmacol Exp Ther; 2015 Nov 23; 355(2):341-50. PubMed ID: 26359313
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    J Pharmacol Exp Ther; 2005 Apr 23; 313(1):352-8. PubMed ID: 15579492
    [Abstract] [Full Text] [Related]

  • 18. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
    Haller VL, Stevens DL, Welch SP.
    Eur J Pharmacol; 2008 Dec 14; 600(1-3):50-8. PubMed ID: 18762181
    [Abstract] [Full Text] [Related]

  • 19. Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat.
    Cross-Mellor SK, Ossenkopp KP, Piomelli D, Parker LA.
    Psychopharmacology (Berl); 2007 Feb 14; 190(2):135-43. PubMed ID: 17111174
    [Abstract] [Full Text] [Related]

  • 20. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
    Russo R, Loverme J, La Rana G, Compton TR, Parrott J, Duranti A, Tontini A, Mor M, Tarzia G, Calignano A, Piomelli D.
    J Pharmacol Exp Ther; 2007 Jul 14; 322(1):236-42. PubMed ID: 17412883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.